Poon To Retire From J&J; New Presidents At CTI Europe, Inotek & Synageva
Executive Summary
President & CEO
You may also be interested in...
J&J Reorganizes Again; Scodari Announces Retirement, Poon Will Take Over
In its latest restructuring move, announced Nov. 15, Johnson & Johnson - a model for diversified health care companies - is focusing on providing integrated health solutions rather than individual products
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials